Current NDC auxiliary source row compounder:3072

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 71139-6030
Product Ndc: 71139-6030
Product Ndc Digits: 711396030
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Fentanyl Citrate CADD
Proprietary Name Suffix: [empty]
Nonproprietary Name: Fentanyl Citrate CADD
Dosage Form Name: INJECTION
Route Name: INTRAVENOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: IntegraDose Compounding Services, LLC
Establishment Name: IntegraDose Compounding Services, LLC
Establishment Fei: [empty]
Substance Name: FENTANYL CITRATE
Active Ingredients Info: 2500 ug/50 mL
History Active Ingredients Raw: FENTANYL CITRATE
History Active Ingredients Info Raw: 2500 ug/50 mL
History Dosage Raw: INJECTION
Dea Schedule: CII
Package Ndc Raw: 71139-6030-1
Package Ndc: 71139-6030-1
Package Ndc Digits: 7113960301
Package Ndc11: 71139603001
Package Description: 50 mL in 1 VIAL, PATENT DELIVERY SYSTEM (71139-6030-1)
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:3072
Source Row Number: 3072
Source Row Hash: 2640e116f3eaa6f1735840ba8465d95c1ee3dee41c4764b7a08d7252545926dd
Import Run Id: 20261025T224840Z
Loaded At: 2026-10-25 22:53:27

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAVENOUS",
    "PRODUCTNDC": "71139-6030",
    "DEASCHEDULE": "CII",
    "LABELERNAME": "IntegraDose Compounding Services, LLC",
    "SUBSTANCENAME": "FENTANYL CITRATE",
    "DOSAGEFORMNAME": "INJECTION",
    "NDCPACKAGECODE": "71139-6030-1",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Fentanyl Citrate CADD",
    "REPORTINGPERIOD": "2026-1",
    "NONPROPRIETARYNAME": "Fentanyl Citrate CADD",
    "PACKAGEDESCRIPTION": "50 mL in 1 VIAL, PATENT DELIVERY SYSTEM (71139-6030-1) ",
    "ACTIVEINGREDIENTSINFO": "2500 ug/50 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:3072
Source Row Number: 3072
Status Scope: package
Lookup Ndc: 71139-6030-1
Lookup Ndc Digits: 7113960301
Product Ndc: 71139-6030
Product Ndc Digits: 711396030
Package Ndc: 71139-6030-1
Package Ndc Digits: 7113960301
Package Ndc11: 71139603001
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 2640e116f3eaa6f1735840ba8465d95c1ee3dee41c4764b7a08d7252545926dd
Import Run Id: 20261025T224840Z
Loaded At: 2026-10-25 22:53:27